Sreelakshmi Ravula profile photo

Sreelakshmi Ravula Institution Verified

Sourced from institutional research profiles (UAMS TRI or ARA).

Associate Professor

University of Arkansas for Medical Sciences

faculty

Internal Medicine, College of Medicine

3 h-index 8 pubs 735 cited

Edit your profile

Biography and Research Information

OverviewAI-generated summary

Sreelakshmi Ravula, Associate Professor in Internal Medicine at the University of Arkansas for Medical Sciences, investigates critical care and kidney disease. Her recent publications examine predictors of adverse outcomes in patients with acute kidney injury following cardiac surgery, as well as the role of acidosis in chronic kidney and liver disease. She has also published on complex clinical cases including unresolving hypokalemia and dialysis-associated reactions. Ravula's work also explores novel approaches to reversing anuric acute kidney injury through intra-abdominal pressure reduction. Her research network includes collaborators such as Joseph H. Holthoff and Omar Dodin from the University of Arkansas for Medical Sciences, with whom she has co-authored multiple publications. Ravula's scholarly output is reflected in her h-index of 3 and a total of 735 citations across 8 publications.

Metrics

  • h-index: 3
  • Publications: 8
  • Citations: 735

Selected Publications

  • Perfusion Under Pressure: Reversing Anuric AKI with Targeted Intra-Abdominal Pressure (IAP) Reduction (2025) DOI
  • A Case of Unresolving Hypokalemia (2024) DOI
  • A Curious Case of Dialysis-Associated Reaction (2024) DOI
  • Urinary Complement C3 and Vitamin D-Binding Protein Predict Adverse Outcomes in Patients with Acute Kidney Injury after Cardiac Surgery (2024) DOI
  • No Good Deed: Acidosis in Chronic Kidney and Liver Disease (2023) DOI

Grants & Funding

  • A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PARALLEL-GROUP, ACTIVE CONTROL STUDY OF THE EFFICACY AND SAFETY OF SPARSENTAN FOR THE TREATMENT OF IMMUNOGLOBULIN A NEPHROPATHY (IRB 262333) Travere Therapeutics Principal Investigator
  • No FP attached Retrophin, Inc. - Pass Through: IQVIA, Inc. Principal Investigator
  • Efficacy of Belimumab and Rituximab Compared to Rituximab Alone for the Treatment of Primary Membranous Nephropathy (IRB 274955) NIH/Nat. Inst. of Allergy & Infectious Diseases - Pass Through: Benaroya Research Institute at Virginia Mason Principal Investigator
  • Efficacy of Belimumab and Rituximab Compared to Rituximab Alone for the Treatment of Primary Membranous Nephropathy (IRB 274955) NIH/Nat. Inst. of Allergy & Infectious Diseases - Pass Through: Benaroya Research Institute at Virginia Mason Principal Investigator

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics